These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2443873)

  • 1. Combined intraarterial and systemic chemotherapy for intracerebral tumors.
    Stewart DJ; Grahovac Z; Hugenholtz H; Russell N; Richard M; Benoit B
    Neurosurgery; 1987 Aug; 21(2):207-14. PubMed ID: 2443873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility study of intraarterial vs intravenous cisplatin, BCNU, and teniposide combined with systemic cisplatin, teniposide, cytosine arabinoside, glycerol and mannitol in the treatment of primary and metastatic brain tumors.
    Stewart DJ; Grahovac Z; Hugenholtz H; DaSilva V; Richard MT; Benoit B; Belanger G; Russell N
    J Neurooncol; 1993 Jul; 17(1):71-9. PubMed ID: 8120574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracarotid chemotherapy with a combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), cis-diaminedichloroplatinum (cisplatin), and 4'-O-demethyl-1-O-(4,6-O-2-thenylidene-beta-D-glucopyranosyl) epipodophyllotoxin (VM-26) in the treatment of primary and metastatic brain tumors.
    Stewart DJ; Grahovac Z; Benoit B; Addison D; Richard MT; Dennery J; Hugenholtz H; Russell N; Peterson E; Maroun JA
    Neurosurgery; 1984 Dec; 15(6):828-33. PubMed ID: 6392925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications associated with intra-arterial BCNU administered in combination with vincristine and procarbazine for the treatment of malignant brain tumors.
    Bremer AM; Kleriga E; Nguyen TQ; Balsys R; Northup HM; Gonzalez N; Duarte P; Miller RI
    J Neurooncol; 1984; 2(2):129-32. PubMed ID: 6481425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.
    Rajkumar SV; Buckner JC; Schomberg PJ; Pitot HC; Ingle JN; Cascino TL
    Neurosurgery; 1999 Jan; 44(1):67-73. PubMed ID: 9894965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and systemic chemotherapy for malignant gliomas: a follow-up study.
    West CR; Avellanosa AM; Barua NR; Patel A; Hong CI
    Neurosurgery; 1983 Oct; 13(4):420-6. PubMed ID: 6314173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytosine arabinoside plus cisplatin and other drugs as chemotherapy for gliomas.
    Stewart DJ; Hugenholtz H; DaSilva V; Benoit B; Richard M; Russell N; Maroun J; Verma S
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):110-5. PubMed ID: 3589685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of intracarotid BCNU and cisplatin in primary malignant brain tumors.
    Feun LG; Lee YY; Yung WK; Charnsangavej C; Savaraj N; Tang RA; Wallace S
    Cancer Drug Deliv; 1986; 3(2):147-56. PubMed ID: 3708537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy with carmustine and cisplatin followed by procarbazine, lomustine, and vincristine for adult high-grade astrocytoma.
    Liau CT; Wei KC; Tseng CK; Jung SM
    Chang Gung Med J; 2005 Jan; 28(1):16-23. PubMed ID: 15804144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase-I trial of intracarotid BCNU and cisplatin in patients with malignant intracerebral tumors.
    Feun LG; Wallace S; Yung WK; Lee YY; Leavens ME; Moser R; Savaraj N; Burgess MA; Plager C; Benjamin RS
    Cancer Drug Deliv; 1984; 1(3):239-45. PubMed ID: 6544123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in malignant gliomas with special reference to intra-arterial chemotherapy.
    Watne K; Hannisdal E; Nome O; Hager B; Hirschberg H
    Acta Oncol; 1993; 32(3):307-10. PubMed ID: 8323768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy with carmustine and cisplatin before, during, and after radiotherapy for adult malignant gliomas.
    Kiu MC; Chang CN; Cheng WC; Lin TK; Wong CW; Tang SG; Leung WM; Chen LH; Ho YS; Ng KT
    J Neurooncol; 1995; 25(3):215-20. PubMed ID: 8592171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined chemotherapy with VM 26 and BCNU for recurrent malignant gliomas after operation and irradiation.
    Zander E; de Tribolet N; Wagenknecht L
    Acta Neurochir (Wien); 1978; 42(1-2):97-101. PubMed ID: 696446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot clinical and pharmacokinetic study of intracarotid cisplatin and bleomycin.
    Feun LG; Savaraj N; Lee YY; Landy H; Martinez-Prieto J; Charnsangavej C; Post JD; Lee KF; Wallace S; Bowen B
    Sel Cancer Ther; 1991; 7(1):29-36. PubMed ID: 1718023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective study of the value of chemotherapy as adjuvant therapy to surgery and radiotherapy in grade 3 and 4 gliomas.
    Gundersen S; Lote K; Watne K
    Eur J Cancer; 1998 Sep; 34(10):1565-9. PubMed ID: 9893629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined intra-arterial and systemic chemotherapy for recurrent malignant brain tumors.
    Watne K; Hannisdal E; Nome O; Hager B; Hirschberg H
    Neurosurgery; 1992 Feb; 30(2):223-7. PubMed ID: 1312230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intra-arterial cisplatin and 1,3-bis(2chloroethyl)-1-nitrosourea (BCNU) dosage on radiographic response and regional toxicity in malignant glioma patients: proposal of a new method of intra-arterial dosage calculation.
    Bobo H; Kapp JP; Vance R
    J Neurooncol; 1992 Jul; 13(3):291-9. PubMed ID: 1517805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supraophthalmic carotid infusion for recurrent glioma: rationale, technique, and preliminary results for cisplatin and BCNU.
    Kapp JP; Vance RB
    J Neurooncol; 1985; 3(1):5-11. PubMed ID: 2987427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracarotid cisplatin-based chemotherapy in patients with malignant melanoma and central nervous system (CNS) metastases.
    Feun LG; Lee YY; Plager C; Papadopoulos N; Savaraj N; Charnsangavej C; Benjamin RS; Wallace S
    Am J Clin Oncol; 1990 Oct; 13(5):448-51. PubMed ID: 1699402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
    Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
    Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.